COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT00240422
Brief Title: Trial to Compare the Effects of Either Telmisartan (40-80 mg PO Once Daily) or Ramipril (5-10 mg PO Once Daily) on Renal Endothelial Dysfunction in Hypertensive Patients With Type 2 Diabetes

First Submitted : October 14, 2005
First Submitted that Met QC Criteria : October 14, 2005
First Posted : October 18, 2005 (Estimate)

Last Update Submitted that Met QC Criteria : November 7, 2013
Last Update Posted : November 8, 2013 (Estimate)